• Print

Publish Date

News Releases


Viracor-IBT Laboratories, Inc.’s Zika Virus RT-PCR Test Receives Emergency Use Authorization From the FDA


Test Provides U.S. Physicians and Patients Same Day Results and the Option to Test Urine Alongside Blood


The National Kidney Registry (NKR) and Viracor-IBT Laboratories announced today a partnership to streamline pre-transplant serology testing for kidney donors. The NKR selected Viracor-IBT as the national laboratory to perform infectious disease screening for its 75 member centers. Fast and accurate preoperative serology testing reduces paired kidney exchange or “swap” failures and increases the number of patients transplanted in NKR facilitated swaps. With so many lives involved, time is of the essence and streamlined logistics are critical; delayed test results can delay transplants.


Eurofins Scientific (EUFI.PA), the global leader in bio-analytical testing, and one of the world leaders in genomic services, is pleased to present the results from a recent study1 published in Transplantation2, showing that Viracor-IBT’s ImmuKnow, the FDA-cleared immune cell function assay that detects cell-mediated immunity in immunosuppressed patients, helps improve outcomes in solid organ transplant (SOT) patients. The study demonstrated that the ImmuKnow assay provided additional data which helped optimize immunosuppression, and ultimately improve patient survival rate3.

Read more